Zobrazeno 1 - 10
of 42
pro vyhledávání: '"A.A. Dunk"'
Autor:
Chia-Ming Chu, J. Monjardino, C. Greenfield, M. J. F. Fowler, Eng-Kiong Yeoh, Peter Karayiannis, B. M. Wankya, Anna S.F. Lok, Ching-Lung Lai, A.A. Dunk, H.C. Thomas
Publikováno v:
Journal of Hepatology. 2:218-229
Summary Hundred and ten liver biopsy specimens from various parts of the world were examined for episomal and integrated HBV-DNA sequences. In 54 patients with HBsAg chronic liver disease episomal HBV-DNA was found in 83% of HBeAg-positive patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f3d4070598808b20933d41d5c919e16
https://doi.org/10.1016/s0168-8278(86)80080-0
https://doi.org/10.1016/s0168-8278(86)80080-0
Autor:
Anna S.F. Lok, Sheila Sherlock, A.A. Dunk, Peter Karayiannis, Howard C. Thomas, David M. Novick
Publikováno v:
Hepatology. 5:1132-1138
A previous randomized controlled study has shown a 30% rate of HBe antigen/antibody seroconversion within 1 year of a month course of adenine arabinoside-5'-monophosphate; no seroconversion occurred in the control group. In this study of patients der
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65400ba8f44ab841d584f40c8030fbe2
https://doi.org/10.1002/hep.1840050612
https://doi.org/10.1002/hep.1840050612
Autor:
John A. O. Besson, John Robertson Crawford, H. Deans, P.W. Brunt, N.A.G. Mowat, T.S. Sinclair, J.W. Moore, G. De Lacey, A.A. Dunk
Publikováno v:
Journal of Hepatology. 9:319-325
By means of psychometric testing, we have determined the frequency of latent hepatic encephalopathy in a group of 19 cirrhotics with no clinical evidence of encephalopathy. Magnetic resonance imaging (MRI) of the brain was performed in order to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b13d7ec8f5a782161ee74e5c8b302c38
https://doi.org/10.1016/0168-8278(89)90140-2
https://doi.org/10.1016/0168-8278(89)90140-2
Autor:
S.C. Scott, Iain M. Murray-Lyon, W M Melia, H.C. Thomas, P.J. Johnson, A.A. Dunk, Roger Williams, Anna S.F. Lok
Publikováno v:
Journal of Hepatology. 1:395-404
Summary Thirty-five patients with hepatocellular carcinoma (HCC) have been treated with the Anthracenedione derivative, Mitozantrone. One complete and 5 partial responses were seen in 22 evaluable patients and in a further 4 patients tumour size rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d860370d013f2648dce6acc32f393c0
https://doi.org/10.1016/s0168-8278(85)80777-7
https://doi.org/10.1016/s0168-8278(85)80777-7
Autor:
M. J. F. Fowler, Sheila Sherlock, J. Monjardino, H. Spiliadis, Howard C. Thomas, P. J. Scheuer, A.A. Dunk
Publikováno v:
International Journal of Cancer. 41:17-23
We have examined the clinical, prognostic, aetiological and pathological features of 41 consecutive British patients with hepatocellular carcinoma (HCC). Presenting symptoms were often vague, and patients were generally in poor condition at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3845e85324b7d2c0d6d17994f0fa2950
https://doi.org/10.1002/ijc.2910410105
https://doi.org/10.1002/ijc.2910410105
Publikováno v:
Journal of Hepatology. 4:52-61
A monoclonal antibody, designated K-PLC1, has been produced to a tumour-associated antigen on the cell membrane of the PLC/PRF/5 cell line. Using an indirect immunofluorescence technique this antibody produced membrane staining of three hepatocellula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3996271af9d2a33c96b40f08ce9e37
https://doi.org/10.1016/s0168-8278(87)80009-0
https://doi.org/10.1016/s0168-8278(87)80009-0
Autor:
Sheila Sherlock, Robert Dick, Andrew K. Burroughs, William J. Jenkins, Steven Mackie, Tom O. K. Osuafor, Robert P. Walt, A.A. Dunk
Publikováno v:
New England Journal of Medicine. 309:1539-1542
We conducted a prospective randomized trial of propranolol for the prevention of recurrent variceal bleeding in 48 patients with cirrhosis of the liver. During a follow-up period of up to 21 months, 12 of 26 patients in the propranolol group and 11 o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79749e242eef04848e401b1b9e482055
https://doi.org/10.1056/nejm198312223092502
https://doi.org/10.1056/nejm198312223092502
Publikováno v:
Journal of Hepatology. 2:419-429
We have examined the growth inhibitory effects of human lymphoblastoid interferon (IFN) on the human hepatocellular carcinoma (HCC) cell line PLC/PRF/5. In vitro, PLC/PRF/5 cells were sensitive to the antiproliferative effects of IFN, growth inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2ea64921e9fb64314e2661063e56f53
https://doi.org/10.1016/s0168-8278(86)80053-8
https://doi.org/10.1016/s0168-8278(86)80053-8
Publikováno v:
Scandinavian journal of gastroenterology. 22(10)
We have measured natural killer (NK) cell activity in patients with hepatocellular carcinoma (HCC) and have examined the effects of in vitro and in vivo administration of alpha-interferon (IFN) on NK cell activity. The NK cell cytotoxicity of HCC pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd6239fa644ea7b9e6392e053775563
https://pubmed.ncbi.nlm.nih.gov/2448865
https://pubmed.ncbi.nlm.nih.gov/2448865
Publikováno v:
Alimentary pharmacologytherapeutics. 1(4)
SUMMARY Human lymphoblastoid interferon, in an initial dose of 2.5 MU m−2 weekly i.m., was given with mitozantrone 12 mg m−2 i.v. every 3 weeks to 15 patients with hepatocellular carcinoma. The survival curve for these patients was worse than tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af12cd9bae94f21cc7af684ceb61f85c
https://pubmed.ncbi.nlm.nih.gov/2856513
https://pubmed.ncbi.nlm.nih.gov/2856513